相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MRN complex is an essential effector of DNA damage repair
Shan Qiu et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2021)
The cross-talk between signaling pathways, noncoding RNAs and DNA damage response: Emerging players in cancer progression
Faezeh Malakoti et al.
DNA REPAIR (2021)
Cyclin E in normal physiology and disease states
Chen Chu et al.
TRENDS IN CELL BIOLOGY (2021)
Aberrant methylation of GADD45A is associated with decreased radiosensitivity in cervical cancer through the PI3K/AKT signaling pathway
Meng Lou et al.
ONCOLOGY LETTERS (2021)
p53, cancer and the immune response
Julianne Blagih et al.
JOURNAL OF CELL SCIENCE (2020)
Dual PI3K/mTOR Inhibitor NVP-BEZ235 Enhances Radiosensitivity of Head and Neck Squamous Cell Carcinoma (HNSCC) Cell Lines Due to Suppressed Double-Strand Break (DSB) Repair by Non-Homologous End Joining
Ulrike Schoetz et al.
CANCERS (2020)
ATM, ATR and DNA-PKcs kinases-the lessons from the mouse models: inhibition ≠ deletion
Demis Menolfi et al.
CELL AND BIOSCIENCE (2020)
The PI3K/mTOR dual inhibitor BEZ235 nanoparticles improve radiosensitization of hepatoma cells through apoptosis and regulation DNA repair pathway
Xiaolong Tang et al.
NANOSCALE RESEARCH LETTERS (2020)
Role of PI3K/AKT pathway in cancer: the framework of malignant behavior
Ningni Jiang et al.
MOLECULAR BIOLOGY REPORTS (2020)
Radiosensitising Cancer Using Phosphatidylinositol-3-Kinase (PI3K), Protein Kinase B (AKT) or Mammalian Target of Rapamycin (mTOR) Inhibitors
Kasun Wanigasooriya et al.
CANCERS (2020)
Targeting the PI3K pathway and DNA damage response as a therapeutic strategy in ovarian cancer
Tzu-Ting Huang et al.
CANCER TREATMENT REVIEWS (2020)
BRCA1 subcellular localization regulated by PI3K signaling pathway in triple-negative breast cancer MDA-MB-231 cells and hormone-sensitive T47D cells
Bin Ma et al.
OPEN LIFE SCIENCES (2020)
Graphene oxide and reduced graphene oxide: Efficient cargo platforms for cancer theranostics
Forough Alemi et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2020)
Metformin inhibits cervical cancer cell proliferation by modulating PI3K/Akt-induced major histocompatibility complex class I-related chain A gene expression
Chenglai Xia et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Inhibition of AKT-Signaling Sensitizes Soft Tissue Sarcomas (STS) and Gastrointestinal Stromal Tumors (GIST) to Doxorubicin via Targeting of Homology-Mediated DNA Repair
Sergei Boichuk et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
DNA-PK in human malignant disorders: Mechanisms and implications for pharmacological interventions
Michaela Medova et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Evolution of PIKK family kinase inhibitors: A new age cancer therapeutics
Althaf Shaik et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2020)
Low dose novel PARP-PI3K inhibition via nanoformulation improves colorectal cancer immunoradiotherapy
M. R. Landry et al.
MATERIALS TODAY BIO (2020)
Inhibition of Nuclear PTEN Tyrosine Phosphorylation Enhances Glioma Radiation Sensitivity through Attenuated DNA Repair
Jianhui Ma et al.
CANCER CELL (2019)
ATM in DNA repair in cancer
Mei Hua Jin et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Inhibition of PTEN activates bovine non-growing follicles in vitro but increases DNA damage and reduces DNA repair response
Mila Maidarti et al.
HUMAN REPRODUCTION (2019)
Crosstalk between Phosphoinositide 3-kinase/Akt signaling pathway with DNA damage response and oxidative stress in cancer
Ansar Karimian et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
mTOR kinase leads to PTEN-loss-induced cellular senescence by phosphorylating p53
Seung Hee Jung et al.
ONCOGENE (2019)
Positive Effects of PI3K/Akt Signaling Inhibition on PTEN and P53 in Prevention of Acute Lymphoblastic Leukemia Tumor Cells
Elahe Naderali et al.
ADVANCED PHARMACEUTICAL BULLETIN (2019)
Cardiac Nuclear High-Mobility Group Box 1 Ameliorates Pathological Cardiac Hypertrophy by Inhibiting DNA Damage Response
Tetsuya Takahashi et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2019)
mTORC1 pathway in DNA damage response
Yinxing Ma et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2018)
DNA-PK, ATM, and ATR: PIKKing on p53
Amanda K. Ashley et al.
CELL CYCLE (2018)
DNA Damage, Mutagenesis and Cancer
Ashis K. Basu
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Combination therapy Eve and Pac to induce apoptosis in cervical cancer cells by targeting PI3K/AKT/mTOR pathways
Pingping Dong et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2018)
Members of FOX family could be drug targets of cancers
Jinhua Wang et al.
PHARMACOLOGY & THERAPEUTICS (2018)
p53 promotes its own polyubiquitination by enhancing the HDM2 and HDMX interaction
Ixaura Medina-Medina et al.
PROTEIN SCIENCE (2018)
Dual PI3K/mTOR inhibitor BEZ235 as a promising therapeutic strategy against paclitaxel-resistant gastric cancer via targeting PI3K/Akt/mTOR pathway
Dongshao Chen et al.
CELL DEATH & DISEASE (2018)
Inhibition of PI3K/AKT Signaling Pathway Radiosensitizes Pancreatic Cancer Cells with ARID1A Deficiency in Vitro
Lin Yang et al.
JOURNAL OF CANCER (2018)
HMGB1 knockdown increases MM cell vulnerability by regulating autophagy and DNA damage repair
Xing Guo et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Photothermal treatment with EGFRmAb-AuNPs induces apoptosis in hypopharyngeal carcinoma cells via PI3K/AKT/mTOR and DNA damage response pathways
Yingying Zhang et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2018)
NF-kappa B Activation in Lymphoid Malignancies: Genetics, Signaling, and Targeted Therapy
Paula Grondona et al.
BIOMEDICINES (2018)
ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response
Andrew N. Blackford et al.
MOLECULAR CELL (2017)
Radiosensitization of the PI3K inhibitor HS-173 through reduction of DNA damage repair in pancreatic cancer
Jung Hee Park et al.
ONCOTARGET (2017)
PTEN in the maintenance of genome integrity: From DNA replication to chromosome segregation
Sheng-Qi Hou et al.
BIOESSAYS (2017)
The emerging role of PI3K/AKT-mediated epigenetic regulation in cancer
Jennifer M. Spangle et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2017)
Inhibition of B7-H3 reverses oxaliplatin resistance in human colorectal cancer cells
Pengfei Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
DNA repair and damage pathways in breast cancer development and therapy
Maryam Majidinia et al.
DNA REPAIR (2017)
Targeting PI3K Signaling in Combination Cancer Therapy
Elvire Pons-Tostivint et al.
TRENDS IN CANCER (2017)
Decreased levels of baseline and drug-induced tubulin polymerisation are hallmarks of resistance to taxanes in ovarian cancer cells and are associated with epithelial-to-mesenchymal transition
George E. Duran et al.
BRITISH JOURNAL OF CANCER (2017)
AKT/PKB Signaling: Navigating the Network
Brendan D. Manning et al.
CELL (2017)
HMGB1 interacts with XPA to facilitate the processing of DNA interstrand crosslinks in human cells
Anirban Mukherjee et al.
NUCLEIC ACIDS RESEARCH (2016)
Synergistic cytotoxicity of BIIB021 with triptolide through suppression of PI3K/Akt/mTOR and NF-κB signal pathways in thyroid carcinoma cells
Si Hyoung Kim et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
Persistent Activation of NF-κB in BRCA1-Deficient Mammary Progenitors Drives Aberrant Proliferation and Accumulation of DNA Damage
Andrea Sau et al.
CELL STEM CELL (2016)
PI3K/Akt/mTOR and Ras/Raf/MEK/ERK signaling pathways inhibitors as anticancer agents: Structural and pharmacological perspectives
Vivek Asati et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
p19Arf is required for the cellular response to chronic DNA damage
K. T. Bieging-Rolett et al.
ONCOGENE (2016)
Hyperglycemia and Phosphatidylinositol 3-Kinase/Protein Kinase B/Mammalian Target of Rapamycin (PI3K/AKT/mTOR) Inhibitors in Phase I Trials: Incidence, Predictive Factors, and Management
Khurum H. Khan et al.
ONCOLOGIST (2016)
Phosphoinositide 3-kinase inhibitors induce DNA damage through nucleoside depletion
Ashish Juvekar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Chromatin remodeling gene AT-rich interactive domain-containing protein 1A suppresses gastric cancer cell proliferation by targeting PIK3CA and PDK1
Qian Zhang et al.
ONCOTARGET (2016)
Mechanisms of ATM Activation
Tanya T. Paull
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 84 (2015)
DNA damage response - A double-edged sword in cancer prevention and cancer therapy
Hui Tian et al.
CANCER LETTERS (2015)
PTEN regulates RPA1 and protects DNA replication forks
Guangxi Wang et al.
CELL RESEARCH (2015)
Targeting PI3K/Akt/mTOR signaling pathway in the treatment of prostate cancer radioresistance
Lei Chang et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2015)
Targeting EGFR-PI3K-AKT-mTOR signaling enhances radiosensitivity in head and neck squamous cell carcinoma
Dominik Horn et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
Mechanism of the inhibition of leukemia cell growth and induction of apoptosis through the activation of ATR and PTEN by the topoisomerase inhibitor 3EZ, 20Ac-ingenol
Shohei Miyata et al.
LEUKEMIA RESEARCH (2015)
Akt-Mediated Phosphorylation of XLF Impairs Non-Homologous End-Joining DNA Repair
Pengda Liu et al.
MOLECULAR CELL (2015)
HMGB1 bound to cisplatin-DNA adducts undergoes extensive acetylation and phosphorylation in vivo
Yafeng He et al.
CHEMICAL SCIENCE (2015)
PTEN Controls the DNA Replication Process through MCM2 in Response to Replicative Stress
Jiawen Feng et al.
CELL REPORTS (2015)
The PTEN/PI3K/Akt signaling pathway mediates HMGB1-induced cell proliferation by regulating the NF-κB/cyclin D1 pathway in mouse mesangial cells
Xiao-Juan Feng et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2014)
PI3K/AKT signaling pathway and cancer: an updated review
Miriam Martini et al.
ANNALS OF MEDICINE (2014)
DNA-PK phosphorylation of RPA32 Ser4/Ser8 regulates replication stress checkpoint activation, fork restart, homologous recombination and mitotic catastrophe
Amanda K. Ashley et al.
DNA REPAIR (2014)
BRCA1 establishes DNA damage signaling and pericentric heterochromatin of the X chromosome in male meiosis
Tyler J. Broering et al.
JOURNAL OF CELL BIOLOGY (2014)
Role of AKT signaling in DNA repair and clinical response to cancer therapy
Qun Liu et al.
NEURO-ONCOLOGY (2014)
Suppression of Akt-mTOR Pathway-A Novel Component of Oncogene Induced DNA Damage Response Barrier in Breast Tumorigenesis
Anjana Bhardwaj et al.
PLOS ONE (2014)
Inhibition of Phosphatidylinositol 3-Kinase/AKT Signaling by NVP-BKM120 Promotes ABT-737-Induced Toxicity in a Caspase-Dependent Manner through Mitochondrial Dysfunction and DNA Damage Response in Established and Primary Cultured Glioblastoma Cells
Esther P. Jane et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
SMG-1 suppresses CDK2 and tumor growth by regulating both the p53 and Cdc25A signaling pathways
Evgenia Gubanova et al.
CELL CYCLE (2013)
mTOR regulates DNA damage response through NF-κB-mediated FANCD2 pathway in hematopoietic cells
F. Guo et al.
LEUKEMIA (2013)
Development of PI3K inhibitors: lessons learned from early clinical trials
Jordi Rodon et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
DNA-PK, ATM and ATR collaboratively regulate p53-RPA interaction to facilitate homologous recombination DNA repair
M. A. Serrano et al.
ONCOGENE (2013)
Phosphoproteomic characterization of DNA damage response in melanoma cells following MEK/PI3K dual inhibition
Donald S. Kirkpatrick et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Nuclear PTEN Controls DNA Repair and Sensitivity to Genotoxic Stress
C. Bassi et al.
SCIENCE (2013)
DNA Damage Sensing by the ATM and ATR Kinases
Alexandre Marechal et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
The Dual PI3K/mTOR Inhibitor NVP-BEZ235 Is a Potent Inhibitor of ATM- and DNA-PKCs-Mediated DNA Damage Responses
Bipasha Mukherjee et al.
NEOPLASIA (2012)
Akt: A Double-Edged Sword in Cell Proliferation and Genome Stability
Naihan Xu et al.
JOURNAL OF ONCOLOGY (2012)
The Extending Network of FOXO Transcriptional Target Genes
Kristan E. van der Vos et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
PTEN Positively Regulates UVB-Induced DNA Damage Repair
Mei Ming et al.
CANCER RESEARCH (2011)
p21WAF1 is component of a positive feedback loop that maintains the p53 transcriptional program
Lisa Y. Pang et al.
CELL CYCLE (2011)
The RNA surveillance protein SMG1 activates p53 in response to DNA double-strand breaks but not exogenously oxidized mRNA
Jennifer S. Gewandter et al.
CELL CYCLE (2011)
Quantitative Nuclear Proteomics Identifies mTOR Regulation of DNA Damage Response
Sricharan Bandhakavi et al.
MOLECULAR & CELLULAR PROTEOMICS (2010)
AKT regulates BRCA1 stability in response to hormone signaling
Andrew C. Nelson et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Multiple roles of the cell cycle inhibitor p21CDKN1A in the DNA damage response
Ornella Cazzalini et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2010)
Smg1 is required for embryogenesis and regulates diverse genes via alternative splicing coupled to nonsense-mediated mRNA decay
David R. McIlwain et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Microtubules and resistance to tubulin-binding agents
Maria Kavallaris
NATURE REVIEWS CANCER (2010)
Common mechanisms of PIKK regulation
Courtney A. Lovejoy et al.
DNA REPAIR (2009)
Emerging common themes in regulation of PIKKs and PI3Ks
Harri Lempiaeinen et al.
EMBO JOURNAL (2009)
Histone Ubiquitination Associates with BRCA1-Dependent DNA Damage Response
Jiaxue Wu et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Chromatin-associated proteins HMGB1/2 and PDIA3 trigger cellular response to chemotherapy-induced DNA damage
Natalia F. Krynetskaia et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Cytoplasmic functions of the tumour suppressor p53
Douglas R. Green et al.
NATURE (2009)
PI3K-Akt signaling regulates basal, but MAP-kinase signaling regulates radiation-induced XRCC1 expression in human tumor cells in vitro
Mahmoud Toulany et al.
DNA REPAIR (2008)
ATR: an essential regulator of genome integrity
Karlene A. Cimprich et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
High mobility group protein B1 enhances DNA repair and chromatin modification after DNA damage
Sabine S. Lange et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
CCDC98 targets BRCA1 to DNA damage sites
Zixing Liu et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2007)
Inhibition of phosphatidylinositol-3-OH kinase/Akt signaling impairs DNA repair in glioblastoma cells following ionizing radiation
Gary D. Kao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Ubiquitin-binding protein RAP80 mediates BRCA1-dependent DNA damage response
Hongtae Kim et al.
SCIENCE (2007)
DNA damage checkpoints: from initiation to recovery or adaptation
Jiri Bartek et al.
CURRENT OPINION IN CELL BIOLOGY (2007)
Essential role for nuclear PTEN in maintaining chromosomal integrity
Wen Hong Shen et al.
CELL (2007)
Activation of p53-dependent growth suppression in human cells by mutations in PTEN or PIK3CA
Jung-Sik Kim et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Glycolysis inhibition for anticancer treatment
H. Pelicano et al.
ONCOGENE (2006)
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Jeffrey A. Engelman et al.
NATURE REVIEWS GENETICS (2006)
Peripheral neuropathy induced by paclitaxel: Recent insights and future perspectives
CD Scripture et al.
CURRENT NEUROPHARMACOLOGY (2006)
TOR signaling in growth and metabolism
S Wullschleger et al.
CELL (2006)
TOR signaling in growth and metabolism
Stephan Wullschleger et al.
CELL (2006)
Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1
Sung Hee Um et al.
CELL METABOLISM (2006)
Interplay between PI3K/Akt and MAPK signaling pathways in DNA-damaging drug-induced apoptosis
Eung-Ryoung Lee et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2006)
The PI3K inhibitor LY294002 prevents p53 induction by DNA damage and attenuates chemotherapy-induced apoptosis
J Bar et al.
CELL DEATH AND DIFFERENTIATION (2005)
Lack of PTEN sequesters CHK1 and initiates genetic instability
J Puc et al.
CANCER CELL (2005)
Chk2 phosphorylation of BRCA1 regulates DNA double-strand break repair
JR Zhang et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Exploiting tumour hypoxia in cancer treatment
JM Brown et al.
NATURE REVIEWS CANCER (2004)
Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes
L Zou et al.
SCIENCE (2003)
ATM and related protein kinases: Safeguarding genome integrity
Y Shiloh
NATURE REVIEWS CANCER (2003)
Mitochondrial bound type II hexokinase: a key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention
PL Pedersen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2002)
BRCA1 induces DNA damage recognition factors and enhances nucleotide excision repair
AR Hartman et al.
NATURE GENETICS (2002)
A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus
LD Mayo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Resistance of primary cultured mouse hepatic tumor cells to cellular senescence despite expression of p16Ink4a, p19Arf, p53, and p21Waf1/Cip1
M Obata et al.
MOLECULAR CARCINOGENESIS (2001)
Triptolide, a novel immunosuppressive and anti-inflammatory agent purified from a Chinese herb Tripterygium Wilfordii Hook F
BJ Chen
LEUKEMIA & LYMPHOMA (2001)
Pex19p dampens the p19ARF-p53-p21WAF1 tumor suppressor pathway
T Sugihara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
p53 induction of heparin-binding EGF-like growth factor counteracts p53 growth suppression through activation of MAPK and PI3K/Akt signaling cascades
L Fang et al.
EMBO JOURNAL (2001)
分享论文
